Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25%

Here's Why Viking Therapeutics Shares Slumped Today

It's been an eventful week for the weight-loss drug company, which continues to impress with its clinical data, and today's move isn't much to worry about.

Viking Therapeutics (NASDAQ:VKTX) Shares Gap Down - Should You Sell?

Viking Therapeutics (NASDAQ:VKTX) Shares Gap Down - Here's What Happened

Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25%

Two biotech stocks are getting crushed while the sector benchmark climbs, and the reasons behind each selloff could not be more different. Understanding what separates a deliberate corporate move from pure micro-cap chaos is the key to reading both situations correctly.

Viking Therapeutics Stock Drops After $500 Million Deal; Cash Runway Nearly Doubles

San Diego, September 24, 2026, 07:10 (PDT) Viking priced 7.86 million new shares at $35 each.The concurrent 2% notes convert initially at $50.75 per share.Base net proceeds of $476.2 million nearly match June liquidity. Viking Therapeutics, Inc. (NASDAQ:VKTX) shares fell 13.6% to $35.99 at 10:05 EDT Thursday. The drop followed a $500 million stock-and-convertible offering…